Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
serenoa repens
- Development stage
- Unknown
- Lead developer
- Laboratorios Q Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Serequr is a pharmaceutical-grade botanical extract of *Serenoa repens* (Saw Palmetto) developed and marketed by Laboratorios Q Pharma. It is primarily indicated for the treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). The extract, typically standardized to a lipidosterolic fraction, exerts its therapeutic effects through several mechanisms, including the inhibition of 5-alpha-reductase (the enzyme responsible for converting testosterone to dihydrotestosterone), anti-inflammatory activity via the inhibition of cyclooxygenase and lipoxygenase pathways, and potential anti-proliferative effects on prostatic tissue. It is an established treatment option in Europe for mild to moderate BPH symptoms.
- Brand names
- Serequr
- Other names
- Saw PalmettoSabal serrulataSerenoa repens extract
02
Targets
SRD5A (Steroid 5-alpha-reductase)PLA2 (Phospholipase A2 group IID)ALOX5 (Arachidonate 5-lipoxygenase)ADRA1A (α1A)COX
Beyond the preview
Go deeper on serenoa repens.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on serenoa repens.